InvestorsHub Logo
Followers 52
Posts 3335
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Tuesday, 11/07/2017 6:15:31 PM

Tuesday, November 07, 2017 6:15:31 PM

Post# of 3283
MD Anderson Pozi trial protocol just updated.

Study increased to 80 patients from 60 which was increased from 30 at the start of the trial.

I was reading the changes to a previous update from July indicating they can treat previously untreated patients with the EGFR Exon 20 mutation. I missed that previously. This is very interesting to say the least! Doesn't say the same about HER2 pts and wondering if that is an oversight.